In addition to the conventional pathophysiology of AD, loss of canonical Wnt signalling has been proved to participate in the progression of AD, whereas activation of Wnt/β-catenin signalling through the LRP6 receptor may promote neurogenesis, synaptic plasticity, and suppress tau phosphorylation and neuroinflammation [158]. Here, MAPT is linked to Alzheimer disease.